Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1346630.RAal29qstuCh2yYk9jzpF1kbURxdmxGLlkZzQelBr1zt4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1346630.RAal29qstuCh2yYk9jzpF1kbURxdmxGLlkZzQelBr1zt4130_assertion type Assertion NP1346630.RAal29qstuCh2yYk9jzpF1kbURxdmxGLlkZzQelBr1zt4130_head.
- NP1346630.RAal29qstuCh2yYk9jzpF1kbURxdmxGLlkZzQelBr1zt4130_assertion description "[We propose: (i) investigations of Cassel's 73-T, an Ehrlich's mouse ascites carcinoma-adapted Newcastle disease virus (NDV) strain that so effectively reduced relapse rates in malignant melanoma if it is an admixture or a recombinant with a murine parvovirus; (ii) transfection of prostatic carcinoma cells with the TRMP gene; (iii) transfection of sarcoma cells with the fas gene followed by treatment with anti-fas monoclonal antibodies, and (iv) treatment of metastatic tumors with a parvovirus incorporating the apoptosis-inducer Ad5 E1A gene.Thus, replicating virions and haphazard generation of cytokines in the inoculated host could be replaced with transfection of single genes of well-defined, limited but selected efficacy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1346630.RAal29qstuCh2yYk9jzpF1kbURxdmxGLlkZzQelBr1zt4130_provenance.
- NP1346630.RAal29qstuCh2yYk9jzpF1kbURxdmxGLlkZzQelBr1zt4130_assertion evidence source_evidence_literature NP1346630.RAal29qstuCh2yYk9jzpF1kbURxdmxGLlkZzQelBr1zt4130_provenance.
- NP1346630.RAal29qstuCh2yYk9jzpF1kbURxdmxGLlkZzQelBr1zt4130_assertion SIO_000772 8583966 NP1346630.RAal29qstuCh2yYk9jzpF1kbURxdmxGLlkZzQelBr1zt4130_provenance.
- NP1346630.RAal29qstuCh2yYk9jzpF1kbURxdmxGLlkZzQelBr1zt4130_assertion wasDerivedFrom befree-2016 NP1346630.RAal29qstuCh2yYk9jzpF1kbURxdmxGLlkZzQelBr1zt4130_provenance.
- NP1346630.RAal29qstuCh2yYk9jzpF1kbURxdmxGLlkZzQelBr1zt4130_assertion wasGeneratedBy ECO_0000203 NP1346630.RAal29qstuCh2yYk9jzpF1kbURxdmxGLlkZzQelBr1zt4130_provenance.